Pulmonary nodules
Conditions
Interventions
Control group (C):DLT intubation was performed
L1 group (airway surface anesthesia group):2% lidocaine 1.5 mg/kg, laryngeal anesthesia tube was used to anesthesia the glottic and subglottic endotracheal surface.
L2 group (single intravenous injection group):2% lidocaine 1.5 mg/kg lidocaine induction period single intravenous injection
L3 group (intravenous continuous pumping group):loading dose of 2% lidocaine was given by a single intravenous injection of 1.5 mg/kg lidocaine during the induction period, and then maintenance dose o
Sponsors
Sichuan Provincial People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1)Age: 18<= Age <=80 years old; (2) ASA I-II; (3) Thoracic surgery patients requiring DLT tracheal intubation; (4) BMI 18-30 kg/m2; (5) Have the ability to comply with the study protocol
Exclusion criteria
Exclusion criteria: (1)Patients with severe heart, lung, and kidney diseases; (2) Forced expiratory volume in the first second [FEV1] or forced vital capacity [FVC]30); (4) Have a history of cold or sore throat within 2 weeks; (5) People who have taken analgesics or used opioids within 7 days; (6) Patients with past intubation difficulties or expected intubation difficulties and possible repeat intubation; (7) The mental state can not cooperate, suffering from mental diseases, no self-control, can not express clearly.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of reactive hypertension induced by intubation during anesthesia induction; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative throat related complications;Postoperative pulmonary complications; | — |
Countries
China
Contacts
Public ContactLi peng
Sichuan Provincial People's Hospital
Outcome results
None listed